MedPath

TASK Applied Science

🇿🇦South Africa
Ownership
Private
Established
2005-01-01
Employees
-
Market Cap
-
Website
https://www.task.org.za/

A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination with Ethionamide

Phase 2
Recruiting
Conditions
Tuberculosis
Interventions
Drug: Alpibectir 45 mg once daily (OD) plus Ethionamide 125 mg OD
Drug: Alpibectir 45 mg OD plus Ethionamide 250 mg OD
Drug: Isoniazid, rifampicin, pyrazinamide and ethambutol fixed dose combination, weight based
Drug: Alpibectir 45 mg OD plus Ethionamide 250 mg OD plus Rifampicin 10 mg/kg OD plus Ethambutol 20 mg/kg OD plus Pyrazinamide 25 mg/kg OD
First Posted Date
2024-12-27
Last Posted Date
2025-03-07
Lead Sponsor
TASK Applied Science
Target Recruit Count
60
Registration Number
NCT06748937
Locations
🇿🇦

TASK, Cape Town, Western Cape, South Africa

Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis

Phase 2
Completed
Conditions
Pulmonary Tuberculosis
Interventions
First Posted Date
2023-06-09
Last Posted Date
2023-06-09
Lead Sponsor
TASK Applied Science
Target Recruit Count
134
Registration Number
NCT05896930
Locations
🇿🇦

TASK Clinical Research Centre, Cape Town, Western Cape, South Africa

A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098

Phase 2
Completed
Conditions
Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
Interventions
First Posted Date
2022-07-25
Last Posted Date
2025-02-20
Lead Sponsor
TASK Applied Science
Target Recruit Count
106
Registration Number
NCT05473195
Locations
🇿🇦

TASK Clinical Research Centre, Cape Town, Western Cape, South Africa

EBA, Safety and Tolerability of Sanfetrinem Cilexetil

Phase 2
Completed
Conditions
Tuberculosis, Pulmonary
Interventions
First Posted Date
2022-05-24
Last Posted Date
2025-02-21
Lead Sponsor
TASK Applied Science
Target Recruit Count
54
Registration Number
NCT05388448
Locations
🇿🇦

TASK Clinical Research Centre, Cape Town, Western Cape, South Africa

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB

Phase 2
Completed
Conditions
Tuberculosis
Interventions
First Posted Date
2020-11-16
Last Posted Date
2022-01-25
Lead Sponsor
TASK Applied Science
Target Recruit Count
22
Registration Number
NCT04629378
Locations
🇿🇦

TASK Clinical Research Centre, Cape Town, Western Cape, South Africa

BCG Vaccination for Healthcare Workers in COVID-19 Pandemic

Phase 3
Completed
Conditions
Sars-CoV2
COVID-19
Interventions
Biological: Bacille Calmette-Guérin (BCG)
Other: Placebo Comparator
First Posted Date
2020-05-07
Last Posted Date
2022-01-25
Lead Sponsor
TASK Applied Science
Target Recruit Count
1000
Registration Number
NCT04379336
Locations
🇿🇦

TASK Foundation, Cape Town, Western Cape, South Africa

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

Phase 2
Completed
Conditions
Pulmonary Tuberculosis
Interventions
Drug: Amoxycillin/clavulanic acid
First Posted Date
2015-01-29
Last Posted Date
2018-09-13
Lead Sponsor
TASK Applied Science
Target Recruit Count
46
Registration Number
NCT02349841
Locations
🇿🇦

TASK Foundation NPC, Cape Town, Western Cape, South Africa

© Copyright 2025. All Rights Reserved by MedPath